Cullen/Frost director granted 630 deferred stock units
Engates John T reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Engates John T reported acquisition or exercise transactions in this Form 4 filing.
Director John T. Engates received a grant of 630 deferred stock units tied to CULLEN/FROST BANKERS, INC. common stock. Each unit represents one share of common stock and vested on April 29, 2026. Following this award, Engates holds 1,360 deferred stock units, which will be settled in shares after his separation from service.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Units | 630 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each deferred stock unit represents the right to receive one share of Cullen/Frost Bankers, Inc. common stock.
- F2. The deferred stock units vested on April 29, 2026. Shares will be delivered to the reporting person on the date when the reporting person experiences a separation from service with Cullen/Frost Bankers, Inc.
Key Figures
Key Terms
Deferred Stock Units financial
separation from service financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CFR director John T. Engates report?
How many Cullen/Frost (CFR) deferred stock units does Engates hold after this Form 4?
When do John T. Engates’ Cullen/Frost deferred stock units vest and settle?
What does each deferred stock unit represent for Cullen/Frost (CFR)?
Is Engates’ Form 4 transaction in CFR a market buy or sell?
AI-generated analysis. How Rhea-AI works. Not financial advice.